Status:
UNKNOWN
Systematic Evaluation of Human Explant Model Systems Engineering
Lead Sponsor:
University Hospital Heidelberg
Collaborating Sponsors:
German Cancer Research Center
Conditions:
Solid Tumor, Adult
Eligibility:
All Genders
18+ years
Brief Summary
All current forms of therapy for tumor patients are essentially based on clinical, genomic or histopathological criteria for the choice of therapy. However, the change in the tissue during therapy is ...
Detailed Description
Personalized therapy is still one of the great goals of oncology. In view of the success of checkpoint inhibitor therapies in selected solid tumors, the question remains why other tumor diseases do no...
Eligibility Criteria
Inclusion
- Tissue material for Explant Model generation available or accessible
Exclusion
- curatively resected/treated tumors
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04671654
Start Date
August 1 2020
End Date
August 1 2025
Last Update
December 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Heidelberg / NCT
Heidelberg, Germany, 69120